ESMO Clinical Practice Guideline Express Update on the management of metastatic pancreatic cancer
Thierry Conroy, Michel Ducreux
Abstract
• This ESMO Clinical Practice Guideline Express Update addresses developments in the management of metastatic pancreatic cancer. • It has been issued following the approval of first-line nanoliposomal irinotecan (NALIRIFOX regimen). • Updated first- and second-line treatment recommendations are provided. • An updated management algorithm for metastatic pancreatic cancer is also included.
Topics & Concepts
GuidelineMedicinePancreatic cancerCancerClinical PracticeOncologyIntensive care medicineInternal medicineFamily medicinePathologyPancreatic and Hepatic Oncology ResearchColorectal Cancer Treatments and StudiesCancer Genomics and Diagnostics